Cited by 368Medical Imaging Techniques and ApplicationsCancer, Hypoxia, and MetabolismRadiopharmaceutical Chemistry and Applications

The DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index.

Metabolic Positron Emission Tomography Imaging in Cancer Detection and Therapy Response

Open access

Zhu, Aizhi, Lee, Daniel, Shim, Hyunsuk·2011·Seminars in Oncology

DOI 10.1053/j.seminoncol.2010.11.012PMC PMC3075495

Open this paper in CoChat — free account

Abstract

Positron emission tomography (PET) is a noninvasive imaging technique that provides a functional or metabolic assessment of normal tissue or disease conditions. Fluorine 18-fluorodeoxyglucose PET imaging (FDG-PET) is widely used clinically for tumor imaging due to increased glucose metabolism in most types of tumors, and has been shown to improve the diagnosis and subsequent treatment of cancers. We review its use in cancer diagnosis, staging, restaging, and assessment of response to treatment. In addition, other metabolic PET imaging agents in pre-clinical research or clinical trial stages of development are discussed, including amino acid analogs based on increased protein synthesis, and choline, which is based on increased membrane lipid synthesis. Amino acid analogs and choline are more specific to tumor cells than FDG, so they play an important role in differentiating cancers from benign conditions and in the diagnosis of cancers with low FDG uptake or high background FDG uptake. For decades, researchers have shown that tumors display altered metabolic profiles with elevated uptake of glucose, amino acids, and lipids. This can be used for cancer diagnosis and monitoring of the therapeutic response with excellent signal-to-noise ratios.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.seminoncol.2010.11.012

Cites

120 of 120 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer Statistics, 2010
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Cancer statistics, 2009
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
Semenza, G., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,892
Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1
Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32529 · Cited by 1,752
Staging of Non–Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed Tomography
Lardinois, D., Weder, W., Hany, T. F., Kamel, E. M., Korom, S., Seifert, B., von Schulthess, G. K., & Steinert, H. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022136 · Cited by 1,416
Role of amino acid transport and countertransport in nutrition and metabolism.
Christensen, H. N. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.1.43 · Cited by 1,105
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Self-citation
Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
Osthus, R. C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Wonsey, D. R., Lee, L. A., & Dang, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000023200 · Cited by 876
Self-citation
Clinical Applications of PET in Oncology
ROHREN, E. M., Turkington, T. G., & Coleman, R. E. (2004) · Radiology · doi:10.1148/radiol.2312021185 · Cited by 862 · cited 1×
“Although FDG-PET has shown great success in cancer diagnosis and assessment of treatment response, FDG has the following limitations: (1) increased accumulation of FDG in some benign processes, such as infectious and inflammatory lesions that can give false positive results; (2) low sensitivity in well-differentiated…”

Show all 121 references

Sorted by citations

Items 201–300 of 368

Biomarker selection and imaging design in cancer: A link with biochemical pathways for imminent engineering
Ali, J. S., Ain, N. U., Naz, S., & Zia, M. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03340 · Cited by 8
“Another isotope of choline, 18F-choline (FCH) has much longer half-life in contrast to that of C-11 and shown to be advantageous [44].”
Background
Nuclear medicine and perspective thoughts in the diagnosis and treatment of pheochromocytoma and paraganglioma
Harbi, E., & Aschner, M. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70017 · Cited by 7
“61 In addition, benign or less aggressive tumors may show lower 18 F-FDG uptake, providing information on tumor behavior and potential clinical implications.”
Penalized maximum likelihood simultaneous longitudinal PET image reconstruction with difference‐image priors
Ellis, S., & Reader, A. J. (2018) · Medical Physics · doi:10.1002/mp.12937 · Cited by 6
Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors
Borja, A. J., Saini, J. S., Raynor, W., Ayubcha, C., Werner, T. J., Alavi, A. A., Revheim, M.-E. R., & Nagaraj, C. (2022) · PET Clinics · doi:10.1016/j.cpet.2022.03.002 · Cited by 6
Nanomedicines as Multifunctional Modulators of Melanoma Immune Microenvironment
Carreira, B., Acúrcio, R. C., Matos, A. I., Peres, C., Pozzi, S., Vaskovich‐Koubi, D., Kleiner, R., Bento, M., Satchi‐Fainaro, R., & Florindo, H. F. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000147 · Cited by 6
Drug‐induced cardiomyopathy: Characterization of a rat model by [18F]FDG/PET and [99mTc]MIBI/SPECT
Houson, H. A., Hedrick, A. F., & Awasthi, V. (2020) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12136 · Cited by 6
PET and SPECT Tracer Development via Copper-Mediated Radiohalogenation of Divergent and Stable Aryl-Boronic Esters
Craig, A., Sachse, F., Laube, M., Brandt, F., Kopka, K., & Stadlbauer, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070837 · Cited by 5
Physiologic and Molecular Basis of PET in Cancer Imaging
Mahajan, A., & Cook, G. (2016) · Springer eBooks · doi:10.1007/978-3-319-40070-9_17 · Cited by 5
Distributed ICSA Clustering Approach for Large Scale Protein Sequences and Cancer Diagnosis
Thenmozhi, K., Karthikeyani Visalakshi, N., Shanthi, S. A., & Pyingkodi, M. (2018) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2018.19.11.3105 · Cited by 5
“In general, widely adopted paradigm in cancer diagnosis and treatment is that early cancer detection which increases likelihood of survival (Zhu et al., 2011).”
A comparison study of monoexponential and fractional order calculus diffusion models and 18F-FDG PET in differentiating benign and malignant solitary pulmonary lesions and their pathological types
Luo, Y., Jiang, H., Meng, N., Huang, Z., Li, Z., Feng, P., Fang, T., Fu, F., Yuan, J., Wang, Z., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.907860 · Cited by 5
“(18)F-FDG PET imaging showed the metabolic activity of (18)F-FDG in tumor cells, taking advantage of the fact that the anaerobic glycolysis metabolism of most malignant tumor cells is more vigorous than that of normal tissue cells (35).”
Background
Nuclear Imaging Modalities in the Diagnosis and Management of Thyroid Cancer
Singh, N. K., Hage, N., Ramamourthy, B., Nagaraju, S., & Kappagantu, K. M. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230915103723 · Cited by 5
Quality of Life of Oligometastatic and Polymetastatic Head and Neck Squamous Cell Carcinoma Patients
Berzenji, D., Dorr, M. C., Sewnaik, A., Mast, H., Offerman, M. P. J., de Jong, R. J. B., & Hardillo, J. A. (2024) · The Laryngoscope · doi:10.1002/lary.31325 · Cited by 5
“13 The secondary aim of this study is therefore to reevaluate the survival of the three DM categories in a cohort that underwent more frequent use of FDG-PET in the follow-up.”
Background
Recent advances of injectable radiopharmaceuticals for nuclear imaging and therapy: a new era in nuclear medicine
Qin, Z. (2015) · Materials Technology · doi:10.1080/10667857.2015.1104829 · Cited by 5
First results of a highly granulated 3D CdTe detector module for PET
Chmeissani, M., Kolstein, M., Macias-Montero, J. G., Puigdengoles, C., García, J., Prats, X., & Martínez, R. (2017) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aaa44c · Cited by 5
Types of cancer diagnostics, the current achievements, and challenges
Mukherjee, N., Chatterjee, N., Manna, K., & Saha, K. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823424-2.00022-3 · Cited by 5
Value of Video-Assisted Mediastinal Lymphadenectomy in Mediastinal Staging in Non-Small-Cell Lung Cancer Patients
Greif, K., Herrmann, D., Kaya, T. B., Milobinski, K., Oggiano, M., Ewig, S., Walles, T., Welter, S., & Hecker, E. (2025) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaf347 · Cited by 4
SKA3-mediated hypoxia tolerance and metabolic reprogramming promote liver metastasis in lung adenocarcinoma
Sun, Z., Zhou, M., Song, N., Wang, C., Liu, M., He, S., Ji, F., Chen, J., Xu, L., Zheng, X., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08270-z · Cited by 4
“This reprogramming is crucial for the metastatic process, as changes in metabolism affect not only the energy state of cells but also in ﬂ uence signaling networks and gene expression patterns through the modi ﬁ cation of post-translational substrates and the utilization of cofactors [13, 14].”
Imaging prediction of KRAS mutation in patients with rectal cancer through deep metric learning using pretreatment [18F]Fluorodeoxyglucose positron emission tomography/computed tomography
Wu, K.-C., Chen, S.-W., Hsieh, T., Yen, K., Chang, C.-J., Kuo, Y., Hsu, Y.-J., Chang, R., & Kao, C. (2023) · British Journal of Radiology · doi:10.1259/bjr.20230243 · Cited by 4
Tryptophan Kynurenine Pathway-Based Imaging Agents for Brain Disorders and Oncology—From Bench to Bedside
Stauff, E., Xu, W., Kecskemethy, H. H., Langhans, S. A., Kandula, V. V. R., Averill, L. W., & Yue, X. (2025) · Biomolecules · doi:10.3390/biom15010047 · Cited by 4
“Because Trp-based tracers have a higher specificity than FDG, they play an important role in differentiating malignant cancers from benign conditions or other types of cancer with a different metabolism profile [97].”
Differentiation of tumor sensitivity to photodynamic therapy and early evaluation of treatment effect by nuclear medicine techniques
Liu, J., Ogawa, M., Sakai, T., Takashima, M., Okazaki, S., & Magata, Y. (2013) · Annals of Nuclear Medicine · doi:10.1007/s12149-013-0734-4 · Cited by 4
FDG PET/CT in Type I Glycogen Storage Disease
Manca, C., Claudin, M., Belle, A., Marie, P., & Verger, A. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001103 · Cited by 4
“PET images yielded evidence of a pulmonary infectious focus as well as of: (1) a dramatically enlarged liver leading to a high global FDG uptake, (2) increased bone marrow activity, (3) splenomegalia leading to a high global spleen uptake, (4) a diffuse enhancement in muscle FDG uptake.”
Background
Synthesis and in vivo evaluation of a radiofluorinated ketone body derivative
Mattingly, S. J., Wuest, M., Fine, E. J., Schirrmacher, R., & Wuest, F. R. (2020) · RSC Medicinal Chemistry · doi:10.1039/c9md00486f · Cited by 4
The prognostic value of 18F-fluorodeoxyglucose positron emission tomography/ computed tomography parameters in patients with malignant pleural mesothelioma
Yenigün, B. M. (2021) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2021.20432 · Cited by 4
“The 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) has been utilized to staging of many types of solid tumors.[12-14] Behind standardized uptake value (SUV), prognostic importance of metabolic volumetric parameters such as metabolic tumor volume (MTV) and total lesion glycolys…”
BackgroundMethod
Clinical Application of 18F-FDG-PET Quantification in Hematological Malignancies: Emphasizing Multiple Myeloma, Lymphoma and Chronic Lymphocytic Leukemia
Zadeh, M. Z. (2023) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2023.07.008 · Cited by 4
Mitochondria and Tumor Metabolic Flexibility: Mechanisms and Therapeutic Perspectives
Rovini, A. M. F., Heslop, K. A., & Maldonado, E. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00090-6 · Cited by 5
Early Prediction of Tumor Response: A Future Strategy for Optimizing Cancer Treatment
Ueda, S., & Saeki, T. (2013) · InTech eBooks · doi:10.5772/57120 · Cited by 4
“In addition, it provides quantitative information on tumor glucose metabolic activity, allowing the measurement of metabolic changes and cancer activity shortly after initiation of therapy and before tumor volume reduction [4].”
Background
Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancer
Pretz, J. L., Blake, M. A., Killoran, J. H., Mamon, H. J., Wo, J. Y.-L., Zhu, A. X., & Hong, T. S. (2017) · Practical Radiation Oncology · doi:10.1016/j.prro.2017.09.008 · Cited by 4
Self-citation
PET Scan Misses Cutaneous Melanoma Metastasis with Significant Tumour Size and Tumour Thickness
Tchernev, G., & Popova, L. V. (2017) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2017.221 · Cited by 4
“PET imaging is based exactly on this distinctive feature of tumors, which explains the high sensitivity and specificity of the method when it refers to cancer diagnosis, staging and therapeutic response monitoring [11].”
Early Imaging Biomarker of Myocardial Glucose Adaptations in High-Fat-Diet-Induced Insulin Resistance Model by Using 18F-FDG PET and [U-13C]glucose Nuclear Magnetic Resonance Tracer
Chung, Y., Lu, K., Chiu, S., Lo, C.-J., Hung, L., Huang, J., Cheng, M., Wang, C., Tsai, C., Lin, Y., et al. (2018) · Contrast Media & Molecular Imaging · doi:10.1155/2018/8751267 · Cited by 4
“(18)FFDG can be taken up by glycolytic cells and phosphorylated by hexokinase but was trapped in the cells in its phosphorylated form, due to lacks of a 2′ hydroxyl group needed for subsequent metabolism [31].”
Background
Mitochondrial Proteins as Metabolic Biomarkers and Sites for Therapeutic Intervention in Primary and Metastatic Cancers
Robledo‐Cadena, D. X., Pacheco-Velázquez, S. C., Vargas-Navarro, J. L., Padilla-Flores, J. A., Moreno‐Sánchez, R., & Rodríguez‐Enríquez, S. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575254320231030051124 · Cited by 3
Understanding metastatic involvement of the conus medullaris: a systematic review of clinical presentations, diagnostic approaches, treatment options, and patient outcomes
Badary, A., Kertam, A., El-Ramly, T. A., Abomera, N. E., Salama, E. Y., Abdelaal, S., Monib, F. A., Hernández-Hernández, A., Sanker, V., Atallah, O., et al. (2024) · Journal of Neuro-Oncology · doi:10.1007/s11060-024-04816-x · Cited by 3
Pneumonectomy for lung metastases: the role in the modern era
Mariolo, A. V., Grigoroiu, M., Seguin‐Givelet, A., Brian, E., Gossot, D., & Girard, P. (2020) · Shanghai Chest · doi:10.21037/shc.2019.12.04 · Cited by 3
“The advances in imaging technology (23), the routinely use of pet-scanner for staging (24), the better comprehension of differential patterns of metastatic spread (25) with regards to molecular biology, pathogenesis and response to treatments, allowed to a novel interpretation of the metastatic disease and a better se…”
Background
Exploring State-Of-The-Art Advances in Targeted Nanomedicines for Managing Acute and Chronic Inflammatory Lung Diseases
Maurya, S., Srivastava, R., Arfin, S., Hawthorne, S. J., Jha, N. K., Agrawal, K., Raj, S., Rathi, B., Kumar, A. J., Raj, R., et al. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0437 · Cited by 4
Molecular imaging reveals the heterogeneous progression of tumor cells and tumor stroma: a practice of FDG PET and FAPI PET in diagnosing PSMA-negative bone metastases of progressive prostate cancer
Zhu, L. (2024) · American Journal of Nuclear Medicine and Molecular Imaging · doi:10.62347/hvlf3619 · Cited by 3
“18 F-FDG is frequently thought to perform poorly in PCa imaging because of its unique metabolic properties that result in a low affinity for glucose in metastatic lesions of PCa [28].”
Background
Nuclear Medicine Imaging Techniques in Glioblastomas
Harbi, E., & Aschner, M. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04233-6 · Cited by 3
Challenges in Metabolite Biomarkers as Avenues of Diagnosis and Prognosis of Cancer
Sharma, N. K., Sarode, S. C., Sekar, G., Sonawane, K., & Bomle, D. (2024) · Journal of Cancer Prevention · doi:10.15430/jcp.24.015 · Cited by 3
Imaging in Oncology
Forrest, L. J., & Kraft, S. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2362-5.00006-2 · Cited by 3
Management of PET diagnosed thyroid incidentalomas in British Columbia Canada: Critical importance of the PET report
Wong, J., Liu, K., Siu, C., Jones, S. J. M., Sovka, M., Wilson, D. C., & Wiseman, S. M. (2017) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2017.03.015 · Cited by 3
18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Interpretation Criteria for the Assessment of Therapeutic Response in Patients with Advanced Stage of Lung Cancer
Mazzoletti, A., Gazzilli, M., Albano, D., Giubbini, R., & Bertagna, F. (2022) · Indian Journal of Nuclear Medicine · doi:10.4103/ijnm.ijnm_192_21 · Cited by 3
“[6] 18F‑fluorodeoxyglucose positron emission tomography‑computed tomography (18F‑FDG PET‑CT) is the standard modality for staging, treatment response monitoring and prognosis prediction for a variety of tumors, including NSCLC.[7,8] Measurement This is an open access journal, and articles are distributed under the ter…”
Influential
Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
Lee, C., Jiang, Z. K., Planken, S., Manzuk, L. K., Ortiz, R., Hall, M. P., Noorbehesht, K., Ram, S., Affolter, T., Troche, G. E., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0810 · Cited by 3
Innovations in imaging modalities: a comparative review of MRI, long-axial field-of-view PET, and full-ring CZT-SPECT in detecting bone metastases
MORETTI, R., Meffe, G., Annunziata, S., & Capotosti, A. (2023) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.23.03537-9 · Cited by 3
Advances in Imaging for Metastatic Epidural Spinal Cord Compression: A Comprehensive Review of Detection, Diagnosis, and Treatment Planning
Kasat, P. R., Kashikar, S. V., Parihar, P. H., Sachani, P., Shrivastava, P., Mapari, S. A., Pradeep, U., Bedi, G. N., & Bhangale, P. N. (2024) · Cureus · doi:10.7759/cureus.70110 · Cited by 3
“Positron emission tomography-CT (PET-CT) [40] Combines metabolic activity imaging with anatomical detail from CT.”
Method
Traditional and advanced AI methods used in the area of neuro-oncology
Panda, S., Biswal, S. S., Rath, S. S., & Saxena, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18509-0.00008-6 · Cited by 4
Molecular Imaging Companion Diagnostics
Tully, K. M., Sobol, N. B., Pereira, P. M. R., & Lewis, J. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813539-6.00010-9 · Cited by 4
Mathematical Models for Acid-Mediated Tumor Invasion: From Deterministic to Stochastic Approaches
Hiremath, S. A., & Surulescu, C. (2017) · Lecture notes in computational science and engineering · doi:10.1007/978-3-319-73371-5_3 · Cited by 3
A Comprehensive Review of Federated Learning in Cancer Diagnosis and Prognosis Prediction
Reddy, K. D., Anusha, S., & Ashalatha, N. (2025) · IgMin Research · doi:10.61927/igmin294 · Cited by 2
Overview of Deep Learning Algorithms and Optimizers for Brain Tumor Segmentation
Purohit, N., & Bhatt, C. P. (2025) · Journal of Medical Physics · doi:10.4103/jmp.jmp_12_25 · Cited by 2
“[34]”
Deep Residual Compensation Model for Unsupervised PET Partial Volume Correction
Cui, J., Wu, J., Wu, Z., He, J., Zeng, Q., Chen, Z., & Feng, Y. (2025) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2025.3627516 · Cited by 2
“In oncology, PET has been proven to be an e ﬀ ective method of evaluating tumor metabolic activities and treatment responses, which can assist clinicians to dynamically adjust treatment strategies according to treatment outcomes [2].”
Dual Energy CT in Musculoskeletal Tumors
Chong, C. C. W., Rai, S., & Nicolaou, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-19563-6_9 · Cited by 2
Positron emission mammography in the evaluation of interim response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
Soldevilla-Gallardo, I., Villaseñor‐Navarro, Y., Medina-Ornelas, S., Villarreal-Garza, C. M., Bargalló‐Rocha, E., Caro-Sánchez, C. H. S., Gallardo-Alvarado, L. N., Hernández-Ramírez, R., Arela-Quispe, L., & García-Pérez, F. O. (2018) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2018.05.001 · Cited by 2
Unexplained Pancytopenia in a Patient with 5q35.2-q35.3 Microduplication Encompassing NSD1: A Case Report
Park, S., Lee, G., Koh, E., & Kim, H. (2018) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v12i4.103 · Cited by 2
Biochemical basics of imaging in positron emission tomography in oncology. Part 1
Leontyev, A. V., Рубцова, Н. А., Khalimon, A. I., Khamadeeva, G. F., Кулиев, М. Т., Pylova, I. V., Лазутина, Т. Н., Kostin, A. A., & Каприн, А. Д. (2019) · Medical Visualization · doi:10.24835/1607-0763-2019-4-114-130 · Cited by 2
“После транспорта внутрь клетки 18F-ФДГ фосфорилируется гексокиназой (ключевой гликолитический фермент) и остается внутриклеточно (в отличие от нативной глюкозы, которая включается в дальнейшие реакции гликолиза) в “метаболической ловушке” в виде 18F-ФДГ6-фосфата, что и составляет основу для визуализации ЗНО при помощи…”
Role of Hydrophilic Monomers in α‐Tocopherol‐Based Copolymers in Causing Cell Death by ROS Production
Kitazume, T., Gan, N., Yusa, S., & Ooya, T. (2021) · Macromolecular Chemistry and Physics · doi:10.1002/macp.202100099 · Cited by 2
Image-guided cancer immunotherapy
Ng, T. S. C., & Miller, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90949-5.00013-9 · Cited by 2
Standardized uptake value and metabolic tumor volume measured by 18F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma
Vural, G. U., Akkaş, B. E., & Demirel, B. B. (2014) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2014.08.001 · Cited by 2
Medicinal (Radio) Chemistry: Building Radiopharmaceuticals for the Future
Pijeira, M. S. O., Nunes, P. S. G., Chaviano, S. L., Diaz, A. M. A., DaSilva, J. N., Ricci‐Júnior, E., Alencar, L. M. R., Chen, X. S., & Santos‐Oliveira, R. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230818092634 · Cited by 2
Insertion of synthetic lesions on patient data: a method for evaluating clinical performance differences between PET systems
Maronnier, Q., Robaine, N., Chaltiel, L., Dierickx, L., Cassou‐Mounat, T., Terroir-Cassou-Mounat, M., Vija, L., Vallot, D., Brillouet, S., Lamesa, C., et al. (2024) · EJNMMI Physics · doi:10.1186/s40658-023-00610-2 · Cited by 2
“Positron emission tomography (PET) coupled with computed tomography (CT) is commonly used in oncology at various stages of the management of many cancers, either for diagnosis, treatment follow-up or monitoring [1].”
SUV max as Predictor of Metastatic Disease on 18 F-FDG PET-CT in Hepatocellular Carcinoma
Ashfaq, W., Rehman, K. S., Shahid, A., & Younis, M. N. (2024) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2024.04.394 · Cited by 2
Enhancing Survival Outcome Predictions in Metastatic Non-Small Cell Lung Cancer Through PET Radiomics Analysis
Wang, S., Belemlilga, D., Lei, Y., Ganti, A. K., Lin, C. H., Asif, S., Marasco, J. T., Oh, K., & Zhou, S. (2024) · Cancers · doi:10.3390/cancers16223731 · Cited by 2
“As a functional imaging modality, PET imaging has become a vital tool in oncology for initial staging, detection of regional and distant metastases, identification of tumor recurrences, and assessment of therapeutic response [7–10].”
Biocompatible Nanocomposites for Diagnostic Imaging
Manoj, L., Subair, S. M., Varghese, S., & Rakhimol, K. R. (2025) · Advanced structured materials · doi:10.1007/978-981-96-7450-3_10 · Cited by 2
Placenta specific 1: a novel marker for detection of metastasis in mouse model of breast cancer
Safaei, S., Manshadi, M. D., Golshahi, H., Hashemi, F., Sasani, F., Madjd, Z., & Ghods, R. (2025) · Biomarkers · doi:10.1080/1354750x.2025.2556166 · Cited by 2
“…descriptions of some common techniques are provided. currently, one of the most sensitive imaging techniques for detecting metastasis is Pet scan (Zhu et al. 2011), meanwhile, it has been reported that tumor-to-background signal ratio is insufficient to detect small lesions and micrometastasis…”
Influential
Validación de técnicas de segmentación para la tomografía por emisión de positrones mediante imágenes ex-vivo de piezas quirúrgicas oncológicas
Prieto, E., Martí-Climent, J. M., Gómez, M., García‐Velloso, M. J., Valero, M., Garrastachu, P., Aristu, J., Alcázar, J. L., Torre, W., Hernández, J. L., et al. (2013) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2013.06.010 · Cited by 2
Using Machine Vision of Glycolytic Elements to Predict Breast Cancer Recurrences: Design and Implementation
Petty, H. R. (2022) · Metabolites · doi:10.3390/metabo13010041 · Cited by 2
“From a clinical perspective, the role of glucose uptake in cancer is supported by the ability of fluorodeoxyglucose and positron emission tomography to identify human cancers in vivo [5].”
Background
Nasopharyngeal carcinoma presenting as an inconspicuous primary lesion with extensive cavernous sinus involvement and temporal lobe extension: a case report and review of literature
Pollard, C., Mesko, S. M., Ginsberg, L. E., Kies, M. S., Raza, S. M., Su, S. Y., Tung, S., & Phan, J. (2017) · Clinical Case Reports · doi:10.1002/ccr3.1166 · Cited by 2
“Positron emission tomography (PET) plays a significant role in defining metabolic activity of tumors, determining N and M staging, and assessing response to treatment [16] but is less useful for detection of primary disease [17].”
Computer-Aided Diagnosis (CAD) to Detect Brain Abnormality from PET Image using Artificial Neural Network (ANN)
Kusumawardani, Y., Ratianto, Prajitno, P., & Soejoko, D. S. (2020) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1505/1/012002 · Cited by 2
Clinical Implications of Breast Cancer
Tsiftsis, D.-A. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-68873-2_39 · Cited by 2
Case Report: Early detection of lung carcinoid in an asymptomatic individual by blood-test initiated PET-CT imaging
Burg, S., Smeets, R., Gosau, M., Failing, K., & Grust, A. L. C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1177237 · Cited by 2
Assessment of novel prognostic biomarkers to predict pathological complete response in patients with non-metastatic triple-negative breast cancer using a window of opportunity design
Akshatha, C. R., Halanaik, D., Ganesh, R. N., Kishore, N., Ganesan, P., Kayal, S., Kumar, H., & Dubashi, B. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359241248329 · Cited by 2
New Histopathological Diagnostic Terms and their Codes of the Central Nervous System (CNS) in the International Classification of Diseases for Oncology (ICD-O 3.1) and about the Turkish Version of ICD-O
Canda, M. Ş. (2018) · Journal of Cancer Diagnosis · doi:10.4172/2476-2253.1000112 · Cited by 2
Computer Vision Identifies Recurrent and Nonrecurrent Ductal Carcinoma in Situ Lesions with Special Emphasis on African-American Women
Saatchi, Y., Schanen, P., Cheung, R. A., & Petty, H. R. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.05.018 · Cited by 2
Positron Emission Tomography (PET)
Schaefer, N. G. (2021) · Encyclopedia of pathology · doi:10.1007/978-3-319-28845-1_5273-1 · Cited by 2
Voltage-Dependent Anion Channels and Tubulin: Bioenergetic Controllers in Cancer Cells
Maldonado, E. N., DeHart, D. N., & Lemasters, J. J. (2017) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-319-55539-3_5 · Cited by 1
Unexpected focal fluorodeoxyglucose uptake in main organs; pass through or pass by?
Lee, H., & Hwang, K.-H. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i11.1885 · Cited by 1
The Development and Evaluation of a Novel Highly Selective PET Radiotracer for Targeting BET BD1
Wang, Y., Wang, Y., Xu, Y., Kang, L., Tocci, D. R., & Wang, C. (2024) · Pharmaceuticals · doi:10.3390/ph17101289 · Cited by 1
“This precision is crucial for accurate PET imaging to ensure specificity to targeted tissues or functions [16].”
Background
Compact and cGMP-compliant automated synthesis of [18F]FSPG on the Trasis AllinOne™
Farooq, R., Gendron, T., Edwards, R. S., & Witney, T. H. (2025) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-024-00322-7 · Cited by 1
Temporal Validation of an FDG-PET-Radiomic Model for Distant-Relapse-Free-Survival After Radio-Chemotherapy for Pancreatic Adenocarcinoma
Vincenzi, M. D., Mori, M., Passoni, P., Tummineri, R., Slim, N., Midulla, M., Palazzo, G., Belardo, A., Spezi, E., Picchio, M., et al. (2025) · Cancers · doi:10.3390/cancers17061036 · Cited by 1
Carcinogenesis: An Alternative Hypothesis Comparing Mutagenic Versus Metabolic Models
Alhatem, A., Gagna, C. E., Lambert, M. W., Keenan, E., & Lambert, W. C. (2025) · Biology · doi:10.3390/biology14101314 · Cited by 1
“…observed that many cancers preferentially utilize the pentose phosphate pathway over the tricarboxylic acid (TCA) cycle for energy production [6–16], a metabolic shift now exploited in positron emission tomography (PET) imaging [17], in which metastatic cancer is identified radiographically [17].”
Brain networks involved in cancer treatment response: insights from 18F-FDG PET scans
Namías, M., Perovnik, M., Huff, D. T., Tinetti, C., Azar, M. E., Strašek, K., Hribernik, N., Reberšek, M., Studen, A., Bruno, G. L., et al. (2025) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ae0beb · Cited by 1
“Furthermore, 18 F-FDG PET is a standard tool in oncology, where it is routinely employed to assess tumor metabolism due to the elevated glucose uptake in cancer cells (Zhu et al 2011, Boellaard et al 2014).”
Contrast-enhanced computed tomography versus positron emission tomography/positron emission tomography-computed tomography in suspected lung cancer: a systematic review and meta-analysis of diagnostic accuracy studies
Suri, T. M., Goel, A., Khan, M. A., Tiwari, P., Mittal, S., Hadda, V., Madan, K., & Mohan, A. (2025) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666251395432 · Cited by 1
Cancer detection: Screening tools and biomarker discoveries
Anas, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33263-0.00007-3 · Cited by 1
Response to Neoadjuvant Chemotherapy as a Potential Indicator of Internal Mammary Node Involvement in Early Breast Cancer
Behzadi, S. T., Wider, J., Nano, J., Kiesl, S., Moser, R., Allwohn, L., Maier, S., Klein, E., Schmidt, G. P., Kiechle, M. B., et al. (2026) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2026.07.050 · Cited by 1
Validation of segmentation techniques for positron emission tomography using ex vivo images of oncological surgical specimens
Prieto, E., Martí-Climent, J. M., Gómez, M., García‐Velloso, M. J., Valero, M., Garrastachu, P., Aristu, J., Alcázar, J. L., Torre, W., Hernández, J. L., et al. (2014) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2014.01.007 · Cited by 1
Role of PET in Cancer Diagnosis
Treglia, G. (2013) · CRC Press eBooks · doi:10.1201/b16389-8 · Cited by 1
Detection of Bone Metastases and Evaluation of Therapy Response in Prostate Cancer Patients by Radiolabelled Choline PET/CT
Incerti, E., Mapelli, P., & Picchio, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-42327-2_7 · Cited by 1
Application of Functional Molecular Imaging in Radiation Oncology
Naz, S., Krishna, M. C., & Mitchell, J. B. (2016) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-40854-5_5 · Cited by 1
PET/CT Biological Imaging of Irradiation-Treated Tumors: Which Studies may Lead to an Improvement in Curability?
Pelak, M. J. (2016) · Cancer clinical trials · Cited by 1
Targeting metabolism: A potential strategy for hematological cancer therapy
Tang, X., Chen, F., Xie, L.-C., Liu, S., & Mai, H. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i10.2990 · Cited by 1
Maximum standardized uptake value in 11C-methionine positron emission tomography may predict the prognosis of patients with oral squamous cell carcinoma
Kuroshima, T., Kitagawa, Y., Sato, J., Watanabe, S., Asaka, T., Abe, T., Harada, H., Hirata, K., & Kuge, Y. (2024) · Odontology · doi:10.1007/s10266-024-00946-w · Cited by 1
“Positron emission tomography (PET) imaging allows clinicians to view and assess the metabolic activities of tumor cells, not the anatomical or structural changes in affected sites, by the uptake of radioactive tracers [3].”
Influential
Transformation of Healthcare through Bioimaging and Bioinformatics
Singh, S., & Negi, K. (2024) · International Journal of Pharma Professional’s Research (IJPPR) · doi:10.69580/ijppr.15.2.2024.96-113 · Cited by 1
Locally metastatic mucinous rectal adenocarcinoma: Imaging diagnosis with DW-MRI in comparison with PET-CT
Bozkurt, M., Okutur, K., Aydın, K., Namal, E., Öztürk, A., Balcı, C., & DEMIR, G. (2012) · Oncology Letters · doi:10.3892/ol.2012.663 · Cited by 1
Role of PET/CT in Radiotherapy Treatment Planning
Picchio, M., Incerti, E., & Muzio, N. G. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-40070-9_22 · Cited by 1
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients
Incerti, E., Vanoli, E. G., Broggi, S., Gumina, C., Passoni, P., Slim, N., Fiorino, C., Reni, M., Mapelli, P., Cattaneo, M., et al. (2019) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001065 · Cited by 1
Building Up the Diagnosis of Cardiac Device Infections: The Role of Imaging
Diemberger, I., Lorenzetti, S., & Bonfiglioli, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-46255-0_5 · Cited by 1
A Pulmonary Pleomorphic Carcinoma Patient with Exudative Retinal Detachment Secondary to Choroid Metastasis as Initial Presentation—A Case Report
Feng, K. M., Chen, Y., Chen, J., Lin, L., Tsai, W., & Chen, C. (2021) · Medicina · doi:10.3390/medicina57060539 · Cited by 1
“PET, which uses short-lived radioisotopes, such as fluorine-18 to label glucose, can detect malignancy and be used for staging, restaging, or monitoring treatment responses [17].”
Background
Development of Dual Receptor Enhanced Pre‐Targeting Strategy—A Novel Promising Technology for Immuno‐Positron Emission Tomography Imaging
Sun, L., Gai, Y., Li, Z., Zhang, X., Li, J., Ma, Y., Li, H., Barajas, R., & Zeng, D. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100110 · Cited by 1
Regulation of Glucose Transporters in Cancer Progression
Raj, S., Mishra, M. K., Harihar, S., Kumar, A., Roychoudhury, S., Kumar, A. J., Rathi, B., & Kumar, D. (2021) · Molecular and integrative toxicology · doi:10.1007/978-3-030-83446-3_9 · Cited by 1
Construction of Molecular Probes and Imaging Applications
Pham, W. N. (2022) · Springer eBooks · doi:10.1007/978-981-19-5739-0_6 · Cited by 1
Evaluation of patient-specific cell free DNA assays for monitoring of minimal residual disease in solid tumorsPreprint
Akolkar, D. B., Patil, D., Puranik, S., Puranik, S., Nandre, P. S., Sabale, K. R., Apurwa, S., Bodke, H., Shrivastava, N., Datta, V., et al. (2022) · medRxiv · doi:10.1101/2022.04.07.22273446 · Cited by 1
Multiple Bony Metastatic Lesions and Evaluation of Primary: Case Records of a Cancer Research Centre
Sundriyal, D., Shirsi, N., Gera, A., Bansal, S., Kotwal, S., & Dawar, R. (2015) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-015-0394-z
“FDG , the most commonly used tracer in PET imaging shows variable physiological uptake by normal tissues (high in brown fat, heart, brain, kidneys and bladder), unusual tumour sites, infections, granulomatous diseases like tuberculosis, inflammatory conditions and in cases of hyperglycemia [9, 10].”
Background
Clinical Implications of Breast Cancer
Tsiftsis, D.-A. D. (2013) · Springer eBooks · doi:10.1007/978-88-470-5385-4_49
“Early results from trials using new imaging agents like amino acid analogs and choline fair even better [4].”
Background

Authors: Zhu, A., Lee, D., & Shim, H.
Affiliations: Emory University (US)
Corresponding author: Shim, Hyunsuk
ORCID: Lee, Daniel
Shim, Hyunsuk
Venue: Seminars in Oncology
Publisher: Elsevier BV
Published: 2011-02
Volume: 38
Issue: 1
Pages: 55-69
ISSN: 0093-7754 (ISSN-L)
DOI: 10.1053/j.seminoncol.2010.11.012
PMC: PMC3075495
OpenAlex: W1982620463
Cited by: 368
References: 121
Citations by year: 2026: 16 · 2025: 31 · 2024: 35 · 2023: 24 · 2022: 35 · 2021: 33 · 2020: 38 · 2019: 36 · 2018: 30 · 2017: 26 · 2016: 17 · 2015: 13 · 2014: 11 · 2013: 11 · 2012: 10
FWCI: 8.32
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Seminars in Oncology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (P50CA128301)
Topics: Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
Keywords: FDG-PET, cancer diagnosis, tumor staging, restaging, treatment response assessment, amino acid analogs, choline PET, tumor glucose metabolism, tumor lipid metabolism, tumor imaging agents
MeSH terms: Choline, Humans, Neoplasm Staging, Neoplasms, Sensitivity and Specificity, Tyrosine, Drug Monitoring, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography, Molecular Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metabolic Positron Emission Tomography Imaging in Cancer Detection and Therapy Response

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks